Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.

news_6

HighTide Therapeutics Appoints Jin Chen, Ph.D., as SVP DMPK and Clinical Pharmacology

Alex January 6, 2022

SHENZHEN, China & ROCKVILLE, Md.--(BUSINESS WIRE)--HighTide Therapeutics Inc., a clinical-stage biopharmaceutical company developing treatments for liver diseases, gastrointestinal diseases and...

news_6

PANews’ PARTY AWARD 2021 Winners Announced

Alex January 6, 2022

HONG KONG--(BUSINESS WIRE)--#DAO--In early December 2021, Asia's top influential blockchain media PANews opened submissions for the PANews' Retrospect of the...

Wire Stories

ACNB Corporation Announces Name Change and Rebranding of Insurance Subsidiary

Alex January 6, 2022

GETTYSBURG, Pa., Jan. 06, 2022 (GLOBE NEWSWIRE) -- ACNB Corporation (NASDAQ: ACNB), financial holding company headquartered in Gettysburg, PA, announced...

news_6

Apa Khabar, Malaysia?

Alex January 6, 2022

Shake Shack Plans Malaysia Expansion with 2023 Market Entry NEW YORK--(BUSINESS WIRE)--We’re shaking it up in Malaysia! Shake Shack Inc....

news_6

Hyperion to Pursue U.S. Listing

Alex January 6, 2022

CHARLOTTE, N.C.--(BUSINESS WIRE)--$HYM #3Dprinting--Hyperion Metals Limited (ASX: HYM) (“Company”) is pleased to announce that it plans to pursue a listing...

news_6

Enfusion Elevates Iris Xinwei Wang to Chief Strategy Officer and Lotte Tønsberg to Head of EMEA Sales and Executive Director, EMEA

Alex January 6, 2022

Cloud-based SaaS Provider Continues Bolstering Executive Leadership Team Globally NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE:...

news_6

Oceaneering’s Integrity Management and Digital Solutions Segment Announces Fourth Quarter 2021 Contracts Exceeding $80 Million

Alex January 6, 2022

HOUSTON--(BUSINESS WIRE)--Oceaneering International, Inc. (NYSE:OII) announces that it has been awarded multiple contracts for its Integrity Management and Digital Solutions...

news_6

Venti Technologies Appoints Renowned Autonomous Vehicle Executives to Company Leadership: James Fu and Demian Chong to Help Scale Company’s Autonomous Logistics Business

Alex January 6, 2022

Pioneers in self-driving technology including globally operating autonomous fleets BOSTON--(BUSINESS WIRE)--Venti Technologies, the leader in safe-speed autonomous vehicles logistics systems,...

Wire Stories

Zai Lab Announces NDA Acceptance of Margetuximab for Patients with Pretreated Metastatic HER2-Positive Breast Cancer in China by the NMPA

Alex January 6, 2022

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688),...

Wire Stories

Tier-1 Mobile Network Carrier in Japan Expanding Their 4G Cellular Network with Gilat’s Backhaul over Satellite

Alex January 6, 2022

Gilat receives order for additional VSATs to enable the operator's 4G/LTE network growth PETAH TIKVA, Israel, Jan. 06, 2022 (GLOBE...

news_6

BeiGene to Present at the J.P. Morgan 40th Annual Healthcare Conference

Alex January 6, 2022

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--$bgne #JPMconference--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global science-driven biotechnology company, today announced...

news_6

Allay Therapeutics Establishes Corporate Headquarters in the Bay Area and Expands Base of Operations in Singapore

Alex January 6, 2022

MENLO PARK, Calif.--(BUSINESS WIRE)--Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation,...

getmega

Get the actionable gaming tips and tricks to ace every game you play

Alex January 6, 2022

Why do people love playing games? Do you love playing games with your friends and family? Which games do you...

news_6

China NMPA Approves Tislelizumab as Second- or Third-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Alex January 6, 2022

Tislelizumab is now approved in six indications in China This marks tislelizumab’s third approved lung cancer indication in China and...

news_6

AJC to Host “BIMP-EAGA Tourism Webinar -Japanese market insights and trends post-COVID-19-” on January 12, 2022

Alex January 6, 2022

TOKYO--(BUSINESS WIRE)--The ASEAN-Japan Centre (AJC) will organize a webinar for tourism stakeholders in Brunei Darussalam-Indonesia-Malaysia-Philippines East ASEAN Growth Area or...